日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Increased imaging ligand hydrophilicity and improved pharmacokinetic properties provides enhanced in vivo targeting of fibroblast activation protein.

提高成像配体的亲水性和改善药代动力学特性,可增强成纤维细胞活化蛋白的体内靶向性

Narain Radhika, Nessler Ian, Richardson Paul L, Erickson Jamie E, Wang Yuzhen, Ferri Jacqueline, Knight Heather L, Bryant Shaughn H, Phillips Lucy A, Zhang Liang, Mitra Soumya

Predictive Simulations in Preclinical Oncology to Guide the Translation of Biologics

临床前肿瘤学中的预测模拟指导生物制剂的转化

Dong, Shujun; Nessler, Ian; Kopp, Anna; Rubahamya, Baron; Thurber, Greg M

Key metrics to expanding the pipeline of successful antibody-drug conjugates

拓展成功抗体药物偶联物产品线的关键指标

Nessler, Ian; Menezes, Bruna; Thurber, Greg M

Practical Guide for Quantification of In Vivo Degradation Rates for Therapeutic Proteins with Single-Cell Resolution Using Fluorescence Ratio Imaging

利用荧光比率成像技术以单细胞分辨率定量分析治疗性蛋白质体内降解速率的实用指南

Nessler, Ian; Cilliers, Cornelius; Thurber, Greg M

Quantitative pharmacology in antibody-drug conjugate development: armed antibodies or targeted small molecules?

抗体药物偶联物开发中的定量药理学:武装抗体还是靶向小分子?

Nessler, Ian; Khera, Eshita; Thurber, Greg M